HKU Scholars Hub: Browsing DSpace

Browsing by Author Liew, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 3 to 8 of 8 < previous

	Title	Author(s)	Issue Date
	Effects of atrasentan on markers of liver function in patients with type 2 diabetes and chronic kidney disease Journal:Diabetes, Obesity and Metabolism	Kohan, DE Liew, A Tang, SCW Barratt, J Heerspink, HJL	1-Aug-2023
	Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases Journal:Kidney International	Rovin, BH Adler, SG Barratt, J Bridoux, F Burdge, KA Chan, TM Cook, HT Fervenza, FC Gibson, KL Glassock, RJ Jayne, DRW Jah, V Liew, A Liu, ZH Mejia-Vilet, JM Nester, CM Radhakrishnan, J Rave, EM Reich, HN Ronco, P Sanders, JSF Sethi, S Suzuki, Y Tang, SCW Tesar, V Vivarelli, M Wetzels, JFM Lytvyn, L Craig, JC Tunnicliffe, DJ Howell, M Tonelli, MA Cheung, M Earley, A Floege, J	2021
	Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease Journal:Cardiovascular Diabetology	Smeijer, JD Kohan, DE Rossing, P Correa-Rotter, R Liew, A Tang, SCW De Zeeuw, D Gansevoort, RT Ju, W Lambers, Heerspink HJ	16-Sep-2023
	KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases Journal:Kidney International	Rovin, BH Adler, SG Barratt, J Bridoux, F Burdge, KA Chan, TM Cook, HT Fervenza, FC Gibson, KL Glassock, RJ Jayne, DRW Jha, V Liew, A Liu, ZH Mejia-Vilet, JM Nester, CM Radhakrishnan, J Rave, EM Reich, HN Ronco, P Sanders, JSF Sethi, S Suzuki, Y Tang, SCW Tesar, V Vivarelli, M Wetzels, JFM Floege, J	2021
	Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Journal:Kidney International	Floege, J Barbour, SJ Cattran, DC Hogan, JJ Nachman, PH Tang, SCW Wetzels, JFM Cheung, M Wheeler, DC Winkelmayer, WC Rovin, BH Adler, SG Alpers, CE Ayoub, I Bagga, A Barratt, J Caster, DJ Chan, DTM Chang, A Choo, JCJ Cook, HT Coppo, R Fervenza, FC Fogo, AB Fox, JG Gibson, KL Glassock, RJ Harris, D Hodson, EM Hoxha, E Iseki, K Jennette, JC Jha, V Johnson, DW Kaname, S Katafuchi, R Kitching, AR Lafayette, RA Li, PKT Liew, A Lv, J Malvar, A Maruyama, S Mejía-Vilet, JM Moeller, MJ Mok, CC Nester, CM Noiri, E O'Shaughnessy, MM Özen, S Parikh, SM Park, HC Peh, CA Pendergraft, WF Pickering, MC Pillebout, E Radhakrishnan, J Rathi, M Roccatello, D Ronco, P Smoyer, WE Tesař, V Thurman, JM Trimarchi, H Vivarelli, M Walters, GD Wang, AYM Wenderfer, SE	2019
	Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease Journal:Kidney International	Chan, KW Smeijer, JD Schechter, M Jongs, N Vart, P Kohan, DE Gansevoort, RT Liew, A Tang, SCW Wanner, C De Zeeuw, D Heerspink, HJL	1-Dec-2023

Showing results 3 to 8 of 8 < previous